Pub Date : 2024-08-06DOI: 10.1016/j.joca.2024.08.001
Belinda J. Lawford , Kim L. Bennell , Travis Haber , Michelle Hall , Rana S. Hinman , Filippo Recenti , Andrea Dell’isola
This Year in Review presents key highlights from recent research relating to osteoarthritis rehabilitation and its outcomes, defined as any non-pharmacological and non-surgical treatment that aims to improve osteoarthritis symptoms at any joint. Three databases (Medline, Embase, and CINAHL Plus) were searched between 1 March 2023 to 12 March 2024. Relevant studies were chosen based on the predefined inclusion/exclusion criteria, perceived clinical importance, quality, controversy in the field, or personal interest, and organised into four overarching themes (with 1–5 sub-themes each). The first theme related to uncertainties regarding exercise benefits. New work has challenged the clinical effectiveness of exercise on symptoms, as well as highlighted uncertainty around our understanding of both mechanisms of effects, how to enhance effectiveness and adherence, and which subgroups of people are more or less likely to improve with exercise. However, we also highlight new work confirming the role of exercise as a first-line management strategy. The second theme related to digital modes of service delivery. There was new evidence to support its effectiveness in improving symptoms and clear potential for creating and evaluating new mobile apps. New work also highlighted the potential future role artificial intelligence can have in providing treatment information and recommendations. The third theme related to patient education, and the call for change to the impairment-based narrative that prevails in osteoarthritis information. The fourth theme is related to weight loss. New work compared the effectiveness of different weight loss diets and explored alternative models of weight loss delivery.
{"title":"Osteoarthritis Year In Review 2024: Rehabilitation and outcomes","authors":"Belinda J. Lawford , Kim L. Bennell , Travis Haber , Michelle Hall , Rana S. Hinman , Filippo Recenti , Andrea Dell’isola","doi":"10.1016/j.joca.2024.08.001","DOIUrl":"10.1016/j.joca.2024.08.001","url":null,"abstract":"<div><div>This Year in Review presents key highlights from recent research relating to osteoarthritis rehabilitation and its outcomes, defined as any non-pharmacological and non-surgical treatment that aims to improve osteoarthritis symptoms at any joint. Three databases (Medline, Embase, and CINAHL Plus) were searched between 1 March 2023 to 12 March 2024. Relevant studies were chosen based on the predefined inclusion/exclusion criteria, perceived clinical importance, quality, controversy in the field, or personal interest, and organised into four overarching themes (with 1–5 sub-themes each). The first theme related to uncertainties regarding exercise benefits. New work has challenged the clinical effectiveness of exercise on symptoms, as well as highlighted uncertainty around our understanding of both mechanisms of effects, how to enhance effectiveness and adherence, and which subgroups of people are more or less likely to improve with exercise. However, we also highlight new work confirming the role of exercise as a first-line management strategy. The second theme related to digital modes of service delivery. There was new evidence to support its effectiveness in improving symptoms and clear potential for creating and evaluating new mobile apps. New work also highlighted the potential future role artificial intelligence can have in providing treatment information and recommendations. The third theme related to patient education, and the call for change to the impairment-based narrative that prevails in osteoarthritis information. The fourth theme is related to weight loss. New work compared the effectiveness of different weight loss diets and explored alternative models of weight loss delivery.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 11","pages":"Pages 1405-1412"},"PeriodicalIF":7.2,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141907327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-03DOI: 10.1016/j.joca.2024.07.006
Jessica J. McClure , George D. McIlroy , Rebecca A. Symons , Susan M. Clark , Iain Cunningham , Weiping Han , Karolina Kania , Fabio Colella , Justin J. Rochford , Cosimo De Bari , Anke J. Roelofs
Objective
Obesity increases osteoarthritis (OA) risk due to adipose tissue dysfunction with associated metabolic syndrome and excess weight. Lipodystrophy syndromes exhibit systemic metabolic and inflammatory abnormalities similar to obesity without biomechanical overloading. Here, we used lipodystrophy mouse models to investigate the effects of systemic versus intra-articular adipose tissue dysfunction on the knee.
Methods
Intra-articular adipose tissue development was studied using reporter mice. Mice with selective lipodystrophy of intra-articular adipose tissue were generated by conditional knockout (cKO) of Bscl2 in Gdf5-lineage cells, and compared with whole-body Bscl2 knockout (KO) mice with generalised lipodystrophy and associated systemic metabolic dysfunction. OA was induced by surgically destabilising the medial meniscus (DMM) and obesity by high-fat diet (HFD). Gene expression was analysed by quantitative RT-PCR and tissues were analysed histologically.
Results
The infrapatellar fat pad (IFP), in contrast to overlying subcutaneous adipose tissue, developed from a template established from the Gdf5-expressing joint interzone during late embryogenesis, and was populated shortly after birth by adipocytes stochastically arising from Pdgfrα-expressing Gdf5-lineage progenitors. While female Bscl2 KO mice with generalised lipodystrophy developed spontaneous knee cartilage damage, Bscl2 cKO mice with intra-articular lipodystrophy did not, despite the presence of synovial hyperplasia and inflammation of the residual IFP. Furthermore, male Bscl2 cKO mice showed no worse cartilage damage after DMM. However, female Bscl2 cKO mice showed increased susceptibility to the cartilage-damaging effects of HFD-induced obesity.
Conclusion
Our findings emphasise the prevalent role of systemic metabolic and inflammatory effects in impairing cartilage homeostasis, with a modulatory role for intra-articular adipose tissue.
{"title":"Disentangling the detrimental effects of local from systemic adipose tissue dysfunction on articular cartilage in the knee","authors":"Jessica J. McClure , George D. McIlroy , Rebecca A. Symons , Susan M. Clark , Iain Cunningham , Weiping Han , Karolina Kania , Fabio Colella , Justin J. Rochford , Cosimo De Bari , Anke J. Roelofs","doi":"10.1016/j.joca.2024.07.006","DOIUrl":"10.1016/j.joca.2024.07.006","url":null,"abstract":"<div><h3>Objective</h3><div>Obesity increases osteoarthritis (OA) risk due to adipose tissue dysfunction with associated metabolic syndrome and excess weight. Lipodystrophy syndromes exhibit systemic metabolic and inflammatory abnormalities similar to obesity without biomechanical overloading. Here, we used lipodystrophy mouse models to investigate the effects of systemic versus intra-articular adipose tissue dysfunction on the knee.</div></div><div><h3>Methods</h3><div>Intra-articular adipose tissue development was studied using reporter mice. Mice with selective lipodystrophy of intra-articular adipose tissue were generated by conditional knockout (cKO) of <em>Bscl2</em> in <em>Gdf5</em>-lineage cells, and compared with whole-body <em>Bscl2</em> knockout (KO) mice with generalised lipodystrophy and associated systemic metabolic dysfunction. OA was induced by surgically destabilising the medial meniscus (DMM) and obesity by high-fat diet (HFD). Gene expression was analysed by quantitative RT-PCR and tissues were analysed histologically.</div></div><div><h3>Results</h3><div>The infrapatellar fat pad (IFP), in contrast to overlying subcutaneous adipose tissue, developed from a template established from the <em>Gdf5</em>-expressing joint interzone during late embryogenesis, and was populated shortly after birth by adipocytes stochastically arising from <em>Pdgfrα</em>-expressing <em>Gdf5</em>-lineage progenitors. While female <em>Bscl2</em> KO mice with generalised lipodystrophy developed spontaneous knee cartilage damage, <em>Bscl2</em> cKO mice with intra-articular lipodystrophy did not, despite the presence of synovial hyperplasia and inflammation of the residual IFP. Furthermore, male <em>Bscl2</em> cKO mice showed no worse cartilage damage after DMM. However, female <em>Bscl2</em> cKO mice showed increased susceptibility to the cartilage-damaging effects of HFD-induced obesity.</div></div><div><h3>Conclusion</h3><div>Our findings emphasise the prevalent role of systemic metabolic and inflammatory effects in impairing cartilage homeostasis, with a modulatory role for intra-articular adipose tissue.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 12","pages":"Pages 1552-1565"},"PeriodicalIF":7.2,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-03DOI: 10.1016/j.joca.2024.07.016
Oliver O’Sullivan , Joanne Stocks , Susie Schofield , James Bilzon , Christopher J. Boos , Anthony M.J. Bull , Nicola T. Fear , Fiona E. Watt , Alexander N. Bennett , Stefan Kluzek , Ana M. Valdes
Objective
The ArmeD SerVices TrAuma RehabilitatioN OutComE (ADVANCE) study is investigating long-term combat-injury outcomes; this sub-study aims to understand the association of osteoarthritis (OA) biomarkers with knee radiographic OA (rOA), pain and function in this high-risk population for post-traumatic OA.
Design
ADVANCE compares combat-injured participants with age, rank, deployment and job-role frequency-matched uninjured participants. Post-injury immunoassay-measured serum biomarkers, knee radiographs, Knee Injury and Osteoarthritis Outcome Scale, and six-minute walk tests are reported. The primary analysis, adjusted for age, body mass, socioeconomic status, and ethnicity, was to determine any differences in biomarkers between those with/without combat injury, rOA and pain. Secondary analyses were performed to compare post-traumatic/idiopathic OA, painful/painfree rOA and injury patterns.
Results
A total of 1145 male participants were recruited, aged 34.1 ± 5.4, 8.9 ± 2.2 years post-injury (n = 579 trauma-exposed, of which, traumatic-amputation n = 161) or deployment (n = 566 matched). Cartilage oligomeric matrix protein (COMP) was significantly higher in the combat-injured group compared to uninjured (p = 0.01). Notably, COMP was significantly lower in the traumatic-amputation group compared to non-amputees (p < 0.001), decreasing relative to number of amputations (p < 0.001). Leptin was higher (p = 0.005) and adiponectin lower (p = 0.017) in those with v without knee pain, associated with an increased risk of 22% and 17% for pain, and 46% and 34% for painful rOA, respectively. There were no significant differences between trauma-exposed and unexposed participants with rOA.
Conclusions
The most notable findings of this large, unique study are the similarities between those with rOA regardless of trauma-exposure, the injury-pattern and traumatic-amputation-associated differences in COMP, and the relationship between adipokines and pain.
{"title":"Association of serum biomarkers with radiographic knee osteoarthritis, knee pain and function in a young, male, trauma-exposed population – Findings from the ADVANCE study","authors":"Oliver O’Sullivan , Joanne Stocks , Susie Schofield , James Bilzon , Christopher J. Boos , Anthony M.J. Bull , Nicola T. Fear , Fiona E. Watt , Alexander N. Bennett , Stefan Kluzek , Ana M. Valdes","doi":"10.1016/j.joca.2024.07.016","DOIUrl":"10.1016/j.joca.2024.07.016","url":null,"abstract":"<div><h3>Objective</h3><div>The ArmeD SerVices TrAuma RehabilitatioN OutComE (ADVANCE) study is investigating long-term combat-injury outcomes; this sub-study aims to understand the association of osteoarthritis (OA) biomarkers with knee radiographic OA (rOA), pain and function in this high-risk population for post-traumatic OA.</div></div><div><h3>Design</h3><div>ADVANCE compares combat-injured participants with age, rank, deployment and job-role frequency-matched uninjured participants. Post-injury immunoassay-measured serum biomarkers, knee radiographs, Knee Injury and Osteoarthritis Outcome Scale, and six-minute walk tests are reported. The primary analysis, adjusted for age, body mass, socioeconomic status, and ethnicity, was to determine any differences in biomarkers between those with/without combat injury, rOA and pain. Secondary analyses were performed to compare post-traumatic/idiopathic OA, painful/painfree rOA and injury patterns.</div></div><div><h3>Results</h3><div>A total of 1145 male participants were recruited, aged 34.1 ± 5.4, 8.9 ± 2.2 years post-injury (n = 579 trauma-exposed, of which, traumatic-amputation n = 161) or deployment (n = 566 matched). Cartilage oligomeric matrix protein (COMP) was significantly higher in the combat-injured group compared to uninjured (p = 0.01). Notably, COMP was significantly lower in the traumatic-amputation group compared to non-amputees (p < 0.001), decreasing relative to number of amputations (p < 0.001). Leptin was higher (p = 0.005) and adiponectin lower (p = 0.017) in those with v without knee pain, associated with an increased risk of 22% and 17% for pain, and 46% and 34% for painful rOA, respectively. There were no significant differences between trauma-exposed and unexposed participants with rOA.</div></div><div><h3>Conclusions</h3><div>The most notable findings of this large, unique study are the similarities between those with rOA regardless of trauma-exposure, the injury-pattern and traumatic-amputation-associated differences in COMP, and the relationship between adipokines and pain.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 12","pages":"Pages 1636-1646"},"PeriodicalIF":7.2,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This "Year in Review" presents a curated selection of research themes and individual studies within the clinical osteoarthritis (OA) field, focusing on epidemiology and therapy. The search was conducted in electronic database MEDLINE from March 4, 2023, to March 31, 2024, specifically targeting English-language articles involving human participants. Inclusions were based on perceived importance and relevance to identifying risk factors or advancing OA treatments. A total of 6539 studies were screened by the 5 authors, resulting in 157 studies considered for potential inclusion. Ultimately, 44 studies were selected, uncovering six key OA-related themes: i) the burden of OA (mostly from Global Burden of Disease studies), ii) pain drivers and trajectories, iii) impacts of sex/gender, iv) OA risk factors, and treatments for v) hand and vi) knee OA. The prevalence of OA continues to rise, particularly affecting women, with unclear distinctions in risk factors and treatment responses between sexes. Associations with atopy were demonstrated in two significant databases. Notably, the authors were particularly interested in recent high-quality methodology randomized controlled trials focusing on hand (methotrexate, denosumab, colchicine, topical betamethasone) and knee OA with conflicting results about stem cell injection. These findings collectively contribute to show the growing burden of OA, but also to help the understanding of OA pathophysiology and inform ongoing efforts to enhance management for people with OA.
本 "年度回顾 "精选了临床骨关节炎(OA)领域的研究主题和单项研究,重点关注流行病学和治疗。检索在电子数据库 MEDLINE 中进行,检索时间为 2023 年 3 月 4 日至 2024 年 3 月 31 日,检索对象为涉及人类参与者的英文文章。纳入研究的依据是对识别风险因素或推进 OA 治疗的重要性和相关性的认识。5 位作者共筛选了 6539 项研究,最终有 157 项研究被考虑纳入。最终,44 项研究被选中,揭示了与 OA 相关的六个关键主题:i) OA 负担(大部分来自全球疾病负担研究);ii) 疼痛驱动因素和轨迹;iii) 性别影响;iv) OA 风险因素;v) 手部和 vi) 膝部 OA 的治疗方法。OA 的发病率持续上升,对女性的影响尤为严重,但不同性别在风险因素和治疗反应方面的区别并不明显。两个重要的数据库显示了与过敏症的关系。值得注意的是,作者们对近期的高质量方法学随机对照试验特别感兴趣,这些试验主要针对手部(甲氨蝶呤、地诺苏单抗、秋水仙碱、局部倍他米松)和膝关节OA,而干细胞注射的结果却相互矛盾。这些研究结果共同显示了OA带来的日益沉重的负担,同时也有助于人们了解OA的病理生理学,并为加强OA患者管理的持续努力提供信息。
{"title":"Osteoarthritis year in review 2024: Epidemiology and therapy","authors":"Alice Courties , Inès Kouki , Nadine Soliman , Sylvain Mathieu , Jérémie Sellam","doi":"10.1016/j.joca.2024.07.014","DOIUrl":"10.1016/j.joca.2024.07.014","url":null,"abstract":"<div><div>This \"Year in Review\" presents a curated selection of research themes and individual studies within the clinical osteoarthritis (OA) field, focusing on epidemiology and therapy. The search was conducted in electronic database MEDLINE from March 4, 2023, to March 31, 2024, specifically targeting English-language articles involving human participants. Inclusions were based on perceived importance and relevance to identifying risk factors or advancing OA treatments. A total of 6539 studies were screened by the 5 authors, resulting in 157 studies considered for potential inclusion. Ultimately, 44 studies were selected, uncovering six key OA-related themes: i) the burden of OA (mostly from Global Burden of Disease studies), ii) pain drivers and trajectories, iii) impacts of sex/gender, iv) OA risk factors, and treatments for v) hand and vi) knee OA. The prevalence of OA continues to rise, particularly affecting women, with unclear distinctions in risk factors and treatment responses between sexes. Associations with atopy were demonstrated in two significant databases. Notably, the authors were particularly interested in recent high-quality methodology randomized controlled trials focusing on hand (methotrexate, denosumab, colchicine, topical betamethasone) and knee OA with conflicting results about stem cell injection. These findings collectively contribute to show the growing burden of OA, but also to help the understanding of OA pathophysiology and inform ongoing efforts to enhance management for people with OA.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 11","pages":"Pages 1397-1404"},"PeriodicalIF":7.2,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-31DOI: 10.1016/j.joca.2024.07.011
Win Min Oo , James Linklater
{"title":"Prevalence of osteoarthritis-related imaging abnormalities in asymptomatic healthy adults","authors":"Win Min Oo , James Linklater","doi":"10.1016/j.joca.2024.07.011","DOIUrl":"10.1016/j.joca.2024.07.011","url":null,"abstract":"","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 10","pages":"Pages 1181-1183"},"PeriodicalIF":7.2,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141879160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-30DOI: 10.1016/j.joca.2024.07.009
Tristan Maerz , Dieuwke Schiphof
{"title":"From cartilage to culture: Opportunities for unraveling the complexities of osteoarthritis through sex and gender","authors":"Tristan Maerz , Dieuwke Schiphof","doi":"10.1016/j.joca.2024.07.009","DOIUrl":"10.1016/j.joca.2024.07.009","url":null,"abstract":"","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 9","pages":"Pages 1013-1015"},"PeriodicalIF":7.2,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-26DOI: 10.1016/j.joca.2024.07.010
Tuhina Neogi , Andrea Dell’Isola , Martin Englund , Aleksandra Turkiewicz
Objective
To describe the use of non-steroidal anti-inflammatory drugs (NSAID), opioids, and physiotherapy (PT) among persons with newly diagnosed knee or hip osteoarthritis (OA) with and without NSAID contraindications or precautions.
Design
We used population-based register data to identify adults aged ≥35 as of January 1, 2014, residing in Skåne region (Sweden) between 2004 and 2013, without a previous knee or hip OA diagnosis. Among this cohort, we identified people with incident knee or hip OA diagnosis between 2014 and 2018 and the presence of contraindications to or precautions for oral NSAIDs at the time of OA diagnosis. We estimated the risk of 1) regular oral NSAID use, 2) regular opioid use, and 3) PT during the first year after diagnosis among those with vs. without contraindications or precautions using confounder-adjusted logistic regression with standardization.
Results
We identified 35,173 persons with newly diagnosed OA, of whom 3257 and 8351 had ≥1 contraindication to oral NSAIDs and ≥1 precaution, respectively. Overall, 27% of individuals used oral NSAIDs (with or without opioids or PT), 10% used opioids, and 57% attended PT. Among patients with contraindications, 21% used oral NSAIDs compared to 31% without (absolute adjusted difference −0.06 (95% CIs: −0.08, −0.05)), 53% vs 59% used PT (adjusted difference −0.03 (−0.05, −0.01)), while 14% vs. 8% had prescribed dispensed opioids (adjusted difference 0.02 (0.01, 0.03)). Similar results were observed for those with precautions.
Conclusions
We highlight the need for safer treatment options. People with OA and contraindications/precautions to NSAIDs have a higher risk of opioid use, slightly lower risk of PT use, and continue to be prescribed NSAIDs.
{"title":"Frequent use of prescription NSAIDs among people with knee or hip osteoarthritis despite contraindications to or precautions with NSAIDs","authors":"Tuhina Neogi , Andrea Dell’Isola , Martin Englund , Aleksandra Turkiewicz","doi":"10.1016/j.joca.2024.07.010","DOIUrl":"10.1016/j.joca.2024.07.010","url":null,"abstract":"<div><h3>Objective</h3><div>To describe the use of non-steroidal anti-inflammatory drugs (NSAID), opioids, and physiotherapy (PT) among persons with newly diagnosed knee or hip osteoarthritis (OA) with and without NSAID contraindications or precautions.</div></div><div><h3>Design</h3><div>We used population-based register data to identify adults aged ≥35 as of January 1, 2014, residing in Skåne region (Sweden) between 2004 and 2013, without a previous knee or hip OA diagnosis. Among this cohort, we identified people with incident knee or hip OA diagnosis between 2014 and 2018 and the presence of contraindications to or precautions for oral NSAIDs at the time of OA diagnosis. We estimated the risk of 1) regular oral NSAID use, 2) regular opioid use, and 3) PT during the first year after diagnosis among those with vs. without contraindications or precautions using confounder-adjusted logistic regression with standardization.</div></div><div><h3>Results</h3><div>We identified 35,173 persons with newly diagnosed OA, of whom 3257 and 8351 had ≥1 contraindication to oral NSAIDs and ≥1 precaution, respectively. Overall, 27% of individuals used oral NSAIDs (with or without opioids or PT), 10% used opioids, and 57% attended PT. Among patients with contraindications, 21% used oral NSAIDs compared to 31% without (absolute adjusted difference −0.06 (95% CIs: −0.08, −0.05)), 53% vs 59% used PT (adjusted difference −0.03 (−0.05, −0.01)), while 14% vs. 8% had prescribed dispensed opioids (adjusted difference 0.02 (0.01, 0.03)). Similar results were observed for those with precautions.</div></div><div><h3>Conclusions</h3><div>We highlight the need for safer treatment options. People with OA and contraindications/precautions to NSAIDs have a higher risk of opioid use, slightly lower risk of PT use, and continue to be prescribed NSAIDs.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 12","pages":"Pages 1628-1635"},"PeriodicalIF":7.2,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141788760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-23DOI: 10.1016/j.joca.2024.07.008
Peter Kreitmaier , Diane Swift , J. Mark Wilkinson , Eleftheria Zeggini
Objective
Osteoarthritis is a common and complex joint disorder that shows higher prevalence and greater disease severity in women. Here, we investigate genome-wide methylation profiles of primary chondrocytes from osteoarthritis patients.
Design
We compare genome-wide methylation profiles of macroscopically intact (low-grade) and degraded (high-grade) osteoarthritis cartilage samples matched from osteoarthritis patients undergoing knee replacement surgery. We perform an epigenome-wide association study for cartilage degeneration across 170 patients and separately in 96 women and 74 men.
Results
We reveal widespread epigenetic differences with enrichments of nervous system and apoptosis-related processes. We further identify substantial similarities between sexes, but also sex-specific markers and pathways.
Conclusions
Together, we provide the largest genome-wide methylation profiles of primary cartilage to date with enhanced and sex-specific insights into epigenetic processes underlying osteoarthritis progression.
{"title":"Epigenomic differences between osteoarthritis grades in primary cartilage","authors":"Peter Kreitmaier , Diane Swift , J. Mark Wilkinson , Eleftheria Zeggini","doi":"10.1016/j.joca.2024.07.008","DOIUrl":"10.1016/j.joca.2024.07.008","url":null,"abstract":"<div><h3>Objective</h3><p>Osteoarthritis is a common and complex joint disorder that shows higher prevalence and greater disease severity in women. Here, we investigate genome-wide methylation profiles of primary chondrocytes from osteoarthritis patients.</p></div><div><h3>Design</h3><p>We compare genome-wide methylation profiles of macroscopically intact (low-grade) and degraded (high-grade) osteoarthritis cartilage samples matched from osteoarthritis patients undergoing knee replacement surgery. We perform an epigenome-wide association study for cartilage degeneration across 170 patients and separately in 96 women and 74 men.</p></div><div><h3>Results</h3><p>We reveal widespread epigenetic differences with enrichments of nervous system and apoptosis-related processes. We further identify substantial similarities between sexes, but also sex-specific markers and pathways.</p></div><div><h3>Conclusions</h3><p>Together, we provide the largest genome-wide methylation profiles of primary cartilage to date with enhanced and sex-specific insights into epigenetic processes underlying osteoarthritis progression.</p></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 9","pages":"Pages 1126-1133"},"PeriodicalIF":7.2,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1063458424013141/pdfft?md5=d7ee97fb238eec9dcf5a88b9c7f235c7&pid=1-s2.0-S1063458424013141-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141760127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-18DOI: 10.1016/j.joca.2024.07.007
M. van Middelkoop , D. Schiphof , M. Hattle , J. Simkins , K.L. Bennell , R.S. Hinman , K.D. Allen , J. Knoop , M.E. van Baar , D. Bossen , J. Wallis , M. Hurley , M.A. Holden , S.M.A. Bierma-Zeinstra
Objective
To investigate whether duration of knee symptoms influenced the magnitude of the effect of exercise therapy compared to non-exercise control interventions on pain and physical function in people with knee osteoarthritis (OA).
Method
We undertook an individual participant data (IPD) meta-analysis utilising IPD stored within the OA Trial Bank from randomised controlled trials (RCTs) comparing exercise to non-exercise control interventions among people with knee OA. IPD from RCTs were analysed to determine the treatment effect by considering both study-level and individual-level covariates in the multilevel regression model. To estimate the interaction effect (i.e., treatment x duration of symptoms (dichotomised)), on self-reported pain or physical function (standardised to 0–100 scale), a one-stage multilevel regression model was applied.
Results
We included IPD from 1767 participants with knee OA from 10 RCTs. Significant interaction effects between the study arm and symptom duration (≤1 year vs >1 year, and ≤2 years vs>2 years) were found for short- (∼3 months) (Mean Difference (MD) −3.57, 95%CI −6.76 to −0.38 and −4.12, 95% CI-6.58 to −1.66, respectively) and long-term (∼12 months) pain outcomes (MD −8.33, 95%CI −12.51 to −4.15 and −8.00, 95%CI −11.21 to −4.80, respectively), and long-term function outcomes (MD −5.46, 95%CI −9.22 to −1.70 and −4.56 95%CI −7.33 to-1.80, respectively).
Conclusions
This IPD meta-analysis demonstrated that people with a relatively short symptom duration benefit more from therapeutic exercise than those with a longer symptom duration. Therefore, there seems to be a window of opportunity to target therapeutic exercise in knee OA.
目的研究膝关节症状持续时间是否会影响运动疗法与非运动对照干预对膝关节骨性关节炎(OA)患者疼痛和身体功能的影响程度:我们利用 OA 试验库(OA Trial Bank)中存储的个人参与者数据(IPD)进行了荟萃分析,这些数据来自随机对照试验(RCT),对膝关节 OA 患者进行了运动与非运动对照干预的比较。通过在多层次回归模型中考虑研究水平和个体水平的协变量,对来自随机对照试验的IPD进行分析,以确定治疗效果。为了估计交互效应(即治疗 x 症状持续时间(二分法))对自我报告疼痛或身体功能(标准化为 0-100 分)的影响,我们采用了单阶段多层次回归模型:我们纳入了来自 10 项研究性临床试验的 1767 名膝关节 OA 患者的 IPD。研究臂和症状持续时间(≤1年 vs >1年,≤2年 vs >2年)之间的显著交互效应在短期(约3个月)(平均差(MD)分别为-3.57,95%CI -6.76至-0.38和-4.12,95%CI-6.58至-1.66)和长期(约3个月)(平均差(MD)分别为-3.57,95%CI -6.76至-0.38和-4.12,95%CI-6.58至-1.66)被发现。66)和长期(约12个月)疼痛结果(MD分别为-8.33,95%CI为-12.51至-4.15和-8.00,95%CI为-11.21至-4.80),以及长期功能结果(MD分别为-5.46,95%CI为-9.22至-1.70和-4.56,95%CI为-7.33至-1.80):这项IPD荟萃分析表明,与症状持续时间较长的患者相比,症状持续时间较短的患者从治疗性运动中获益更多。因此,针对膝关节 OA 的治疗性运动似乎存在机会之窗。
{"title":"People with short symptom duration of knee osteoarthritis benefit more from exercise therapy than people with longer symptom duration: An individual participant data meta-analysis from the OA trial bank","authors":"M. van Middelkoop , D. Schiphof , M. Hattle , J. Simkins , K.L. Bennell , R.S. Hinman , K.D. Allen , J. Knoop , M.E. van Baar , D. Bossen , J. Wallis , M. Hurley , M.A. Holden , S.M.A. Bierma-Zeinstra","doi":"10.1016/j.joca.2024.07.007","DOIUrl":"10.1016/j.joca.2024.07.007","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate whether duration of knee symptoms influenced the magnitude of the effect of exercise therapy compared to non-exercise control interventions on pain and physical function in people with knee osteoarthritis (OA).</div></div><div><h3>Method</h3><div>We undertook an individual participant data (IPD) meta-analysis utilising IPD stored within the OA Trial Bank from randomised controlled trials (RCTs) comparing exercise to non-exercise control interventions among people with knee OA. IPD from RCTs were analysed to determine the treatment effect by considering both study-level and individual-level covariates in the multilevel regression model. To estimate the interaction effect (i.e., treatment x duration of symptoms (dichotomised)), on self-reported pain or physical function (standardised to 0–100 scale), a one-stage multilevel regression model was applied.</div></div><div><h3>Results</h3><div>We included IPD from 1767 participants with knee OA from 10 RCTs. Significant interaction effects between the study arm and symptom duration (≤1 year vs >1 year, and ≤2 years vs>2 years) were found for short- (∼3 months) (Mean Difference (MD) −3.57, 95%CI −6.76 to −0.38 and −4.12, 95% CI-6.58 to −1.66, respectively) and long-term (∼12 months) pain outcomes (MD −8.33, 95%CI −12.51 to −4.15 and −8.00, 95%CI −11.21 to −4.80, respectively), and long-term function outcomes (MD −5.46, 95%CI −9.22 to −1.70 and −4.56 95%CI −7.33 to-1.80, respectively).</div></div><div><h3>Conclusions</h3><div>This IPD meta-analysis demonstrated that people with a relatively short symptom duration benefit more from therapeutic exercise than those with a longer symptom duration. Therefore, there seems to be a window of opportunity to target therapeutic exercise in knee OA.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 12","pages":"Pages 1620-1627"},"PeriodicalIF":7.2,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-17DOI: 10.1016/j.joca.2024.07.004
Sultan Ayyadah Alanazi , Bill Vicenzino , Christiaan J.A. van Bergen , David J. Hunter , Erik A. Wikstrom , Hylton B. Menz , Yvonne M. Golightly , Michelle D. Smith , Core Domain Set for Ankle Osteoarthritis Consensus group
Objectives
To develop an internationally agreed-upon core domain set for ankle osteoarthritis (OA).
Methods
In a three-part Delphi process, a group of multidisciplinary health professionals with expertise in ankle OA and people with ankle OA responded to online questionnaires. The questionnaires proposed a list of 29 candidate domains derived from a systematic review of ankle OA research, and interviews with people with ankle OA and health professionals. Consensus was defined a priori as ≥70% agreement in people with ankle OA and health professionals whether a domain should or should not be included in a core domain set. An online consensus meeting was held to discuss and resolve undecided candidate domains.
Results
A total of 100 people (75 health professionals and 25 people with ankle OA) from 18 countries (4 continents) participated in this study. Five domains reached consensus for inclusion in a core domain set for ankle OA – pain severity, health-related quality of life, function, disability and ankle range of motion. Twenty-one candidate domains reached agreement not to be included in the core domain set, and three domains remained undecided (ankle instability, physical capacity, and mental health).
Conclusion
This international consensus study, which included people with ankle OA and health professionals, has established a core domain set for ankle OA with five domains that should be measured and reported in all ankle OA trials – pain severity, health-related quality of life, function, disability and ankle range of motion. This core domain set will guide the reporting of outcomes in clinical trials on ankle OA. Future research should determine which outcome measurement instruments should be used to measure each of the core domains.
目的:为踝关节骨关节炎(OA)制定一套国际公认的核心领域:为踝关节骨关节炎(OA)制定一套国际公认的核心领域:在一个由三部分组成的德尔菲过程中,一组具有踝关节 OA 方面专业知识的多学科医疗专业人士和踝关节 OA 患者对在线问卷做出了回答。调查问卷提出了一份 29 个候选领域的清单,这些领域来自于对踝关节 OA 研究的系统回顾,以及对踝关节 OA 患者和医疗专业人员的访谈。共识的先验定义是,踝关节OA患者和医疗专业人员对某一领域是否应纳入核心领域集的共识度≥70%:共有来自 18 个国家(4 大洲)的 100 人(75 名医疗专业人员和 25 名踝关节 OA 患者)参与了这项研究。有五个领域达成了纳入踝关节 OA 核心领域集的共识:疼痛严重程度、与健康相关的生活质量、功能、残疾和踝关节活动范围。21个候选领域达成共识,不纳入核心领域集,3个领域仍未确定(踝关节不稳定性、体能和心理健康):这项国际共识研究包括了踝关节 OA 患者和医疗专业人员,它确立了踝关节 OA 核心领域集,所有踝关节 OA 试验都应测量和报告这五个领域--疼痛严重程度、与健康相关的生活质量、功能、残疾和踝关节活动范围。该核心领域集将指导踝关节 OA 临床试验结果的报告。未来的研究应确定应使用哪些结果测量工具来测量每个核心领域。
{"title":"Development of a core domain set for ankle osteoarthritis: An international consensus study of patients and health professionals","authors":"Sultan Ayyadah Alanazi , Bill Vicenzino , Christiaan J.A. van Bergen , David J. Hunter , Erik A. Wikstrom , Hylton B. Menz , Yvonne M. Golightly , Michelle D. Smith , Core Domain Set for Ankle Osteoarthritis Consensus group","doi":"10.1016/j.joca.2024.07.004","DOIUrl":"10.1016/j.joca.2024.07.004","url":null,"abstract":"<div><h3>Objectives</h3><div>To develop an internationally agreed-upon core domain set for ankle osteoarthritis (OA).</div></div><div><h3>Methods</h3><div>In a three-part Delphi process, a group of multidisciplinary health professionals with expertise in ankle OA and people with ankle OA responded to online questionnaires. The questionnaires proposed a list of 29 candidate domains derived from a systematic review of ankle OA research, and interviews with people with ankle OA and health professionals. Consensus was defined a priori as ≥70% agreement in people with ankle OA and health professionals whether a domain should or should not be included in a core domain set. An online consensus meeting was held to discuss and resolve undecided candidate domains.</div></div><div><h3>Results</h3><div>A total of 100 people (75 health professionals and 25 people with ankle OA) from 18 countries (4 continents) participated in this study. Five domains reached consensus for inclusion in a core domain set for ankle OA – pain severity, health-related quality of life, function, disability and ankle range of motion. Twenty-one candidate domains reached agreement not to be included in the core domain set, and three domains remained undecided (ankle instability, physical capacity, and mental health).</div></div><div><h3>Conclusion</h3><div>This international consensus study, which included people with ankle OA and health professionals, has established a core domain set for ankle OA with five domains that should be measured and reported in all ankle OA trials – pain severity, health-related quality of life, function, disability and ankle range of motion. This core domain set will guide the reporting of outcomes in clinical trials on ankle OA. Future research should determine which outcome measurement instruments should be used to measure each of the core domains.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"32 11","pages":"Pages 1481-1491"},"PeriodicalIF":7.2,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141727516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}